We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
McDonald's
MCD
$182B
| $24.9M | 0.06% |
83,287
-31,901
| -28% | -$9.27M |
|
327
Camtek
CAMT
$6.25B
| $24.8M | 0.06% |
695,000
| – | – |
|
328
Tenet Healthcare
THC
$21.2B
| $24.6M | 0.06% |
302,708
-74,931
| -20% | -$5.33M |
|
329
LiveRamp
RAMP
$2.29B
| $24.5M | 0.06% |
858,582
-70,636
| -8% | -$1.75M |
|
|
HDV
330
iShares Core High Dividend ETF
HDV
$15.5B
| $24.3M | 0.06% |
1,206,450
+1,167,955
| +3,034% | +$23.5M |
|
|
AXON
331
Axon Enterprise
AXON
$39.8B
| $24.2M | 0.06% |
123,982
-29,355
| -19% | -$6.08M |
|
332
Alphabet (Google) Class C
GOOG
$4.23T
| $24.1M | 0.06% |
199,475
+3,519
| +2% | +$407K |
|
333
Chefs' Warehouse
CHEF
$4.6B
| $24M | 0.06% |
670,833
+66,664
| +11% | +$2.21M |
|
|
MRO
334
DELISTED
Marathon Oil Corporation
MRO
| $23.8M | 0.06% |
1,034,401
-14,759
| -1% | -$348K |
|
335
Valero Energy
VLO
$110B
| $23.7M | 0.06% |
202,285
+76,783
| +61% | +$8.92M |
|
336
MYR Group
MYRG
$4.23B
| $23.6M | 0.06% |
170,678
+593
| +0.3% | +$77.4K |
|
337
Teradyne
TER
$51.5B
| $23.5M | 0.06% |
210,964
-2,003
| -0.9% | -$201K |
|
|
DEA
338
Easterly Government Properties
DEA
$1.13B
| $23.4M | 0.06% |
644,897
-228,400
| -26% | -$8.03M |
|
339
American International
AIG
$39.4B
| $23.4M | 0.06% |
405,838
-43,821
| -10% | -$2.35M |
|
340
Booz Allen Hamilton
BAH
$9.52B
| $23.3M | 0.06% |
208,847
-5,371
| -3% | -$531K |
|
341
Intercontinental Exchange
ICE
$88.4B
| $23.3M | 0.06% |
205,795
-1,842
| -0.9% | -$199K |
|
342
Molina Healthcare
MOH
$11.2B
| $23.3M | 0.06% |
77,192
-431
| -0.6% | -$124K |
|
343
Academy Sports + Outdoors
ASO
$3.41B
| $23.2M | 0.06% |
430,018
-634,628
| -60% | -$36.5M |
|
344
Omnicell
OMCL
$1.53B
| $23.1M | 0.06% |
313,484
-29,978
| -9% | -$2.02M |
|
345
Federated Hermes Short Duration Corporate ETF
FCSH
$66.6M
| $23.1M | 0.06% |
990,004
| – | – |
|
346
Cactus
WHD
$4.85B
| $23M | 0.06% |
542,452
-88,278
| -14% | -$3.44M |
|
347
iQIYI
IQ
$960M
| $22.8M | 0.06% |
+4,278,544
| New | +$24.1M |
|
|
EWCZ
348
DELISTED
European Wax Center
EWCZ
| $22.8M | 0.06% |
1,225,000
| – | – |
|
349
Cintas
CTAS
$80.6B
| $22.8M | 0.06% |
183,208
+1,532
| +0.8% | +$180K |
|
350
Jabil
JBL
$31.3B
| $22.6M | 0.06% |
209,547
-16,862
| -7% | -$1.48M |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.